rs475992

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000231.3(SGCG):​c.578+4524A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.558 in 152,054 control chromosomes in the GnomAD database, including 24,669 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. The gene SGCG is included in the ClinGen Criteria Specification Registry.

Frequency

Genomes: 𝑓 0.56 ( 24669 hom., cov: 32)

Consequence

SGCG
NM_000231.3 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 2.01

Publications

6 publications found
Variant links:
Genes affected
SGCG (HGNC:10809): (sarcoglycan gamma) This gene encodes gamma-sarcoglycan, one of several sarcolemmal transmembrane glycoproteins that interact with dystrophin. The dystrophin-glycoprotein complex (DGC) spans the sarcolemma and is comprised of dystrophin, syntrophin, alpha- and beta-dystroglycans and sarcoglycans. The DGC provides a structural link between the subsarcolemmal cytoskeleton and the extracellular matrix of muscle cells. Defects in the encoded protein can lead to early onset autosomal recessive muscular dystrophy, in particular limb-girdle muscular dystrophy, type 2C (LGMD2C). [provided by RefSeq, Oct 2008]
SACS (HGNC:10519): (sacsin molecular chaperone) This gene encodes the sacsin protein, which includes a UbL domain at the N-terminus, a DnaJ domain, and a HEPN domain at the C-terminus. The gene is highly expressed in the central nervous system, also found in skin, skeletal muscles and at low levels in the pancreas. This gene includes a very large exon spanning more than 12.8 kb. Mutations in this gene result in autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS), a neurodegenerative disorder characterized by early-onset cerebellar ataxia with spasticity and peripheral neuropathy. The authors of a publication on the effects of siRNA-mediated sacsin knockdown concluded that sacsin protects against mutant ataxin-1 and suggest that "the large multi-domain sacsin protein is able to recruit Hsp70 chaperone action and has the potential to regulate the effects of other ataxia proteins" (Parfitt et al., PubMed: 19208651). A pseudogene associated with this gene is located on chromosome 11. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2013]
SACS Gene-Disease associations (from GenCC):
  • Charlevoix-Saguenay spastic ataxia
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Myriad Women's Health, Labcorp Genetics (formerly Invitae), G2P, PanelApp Australia, Laboratory for Molecular Medicine, Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000231.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.824 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000231.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SGCG
NM_000231.3
MANE Select
c.578+4524A>G
intron
N/ANP_000222.2Q13326
SGCG
NM_001378244.1
c.632+4524A>G
intron
N/ANP_001365173.1
SGCG
NM_001378245.1
c.578+4524A>G
intron
N/ANP_001365174.1Q13326

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SGCG
ENST00000218867.4
TSL:1 MANE Select
c.578+4524A>G
intron
N/AENSP00000218867.3Q13326
SACS
ENST00000683210.1
c.2186-10768T>C
intron
N/AENSP00000506739.1A0A804HHS6
SGCG
ENST00000942469.1
c.579-3446A>G
intron
N/AENSP00000612528.1

Frequencies

GnomAD3 genomes
AF:
0.558
AC:
84752
AN:
151936
Hom.:
24663
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.394
Gnomad AMI
AF:
0.633
Gnomad AMR
AF:
0.667
Gnomad ASJ
AF:
0.495
Gnomad EAS
AF:
0.844
Gnomad SAS
AF:
0.568
Gnomad FIN
AF:
0.614
Gnomad MID
AF:
0.669
Gnomad NFE
AF:
0.603
Gnomad OTH
AF:
0.587
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.558
AC:
84786
AN:
152054
Hom.:
24669
Cov.:
32
AF XY:
0.561
AC XY:
41707
AN XY:
74310
show subpopulations
African (AFR)
AF:
0.393
AC:
16307
AN:
41468
American (AMR)
AF:
0.667
AC:
10203
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.495
AC:
1715
AN:
3468
East Asian (EAS)
AF:
0.845
AC:
4354
AN:
5154
South Asian (SAS)
AF:
0.567
AC:
2733
AN:
4820
European-Finnish (FIN)
AF:
0.614
AC:
6489
AN:
10560
Middle Eastern (MID)
AF:
0.664
AC:
194
AN:
292
European-Non Finnish (NFE)
AF:
0.603
AC:
40966
AN:
67982
Other (OTH)
AF:
0.591
AC:
1248
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1832
3664
5495
7327
9159
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
724
1448
2172
2896
3620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.589
Hom.:
113085
Bravo
AF:
0.559
Asia WGS
AF:
0.708
AC:
2464
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
7.5
DANN
Benign
0.79
PhyloP100
2.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs475992;
hg19: chr13-23874150;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.